Observational Study
Copyright ©The Author(s) 2025.
World J Psychiatry. May 19, 2025; 15(5): 104995
Published online May 19, 2025. doi: 10.5498/wjp.v15.i5.104995
Figure 1
Figure 1 Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale, Social Support Rating Scale and Functional Assessment of Cancer Therapy-Hepatobiliary Questionnaire scores in patients with advanced hepatocellular carcinoma. HAMA: Hamilton Anxiety Rating Scale; HAMD: Hamilton Depression Rating Scale; FACT-Hep: Functional Assessment of Cancer Therapy-Hepatobiliary Questionnaire; SSRS: Social Support Rating Scale.
Figure 2
Figure 2 The incidence of anxiety and depression in patients with advanced liver cancer.
Figure 3
Figure 3 Binary logistic regression forest plot of independent influencing factors of depression and anxiety. A: Binary logistic regression forest plot of independent influencing factors of depression; B: Binary logistic regression forest plot of independent influencing factors of anxiety. OR: Odds ratio; FACT-Hep: Functional Assessment of Cancer Therapy-Hepatobiliary Questionnaire; BCLC: Barcelona Clinic Liver Cancer; TACE: Transcatheter arterial chemoembolization; HAIC: Hepatic artery infusion chemotherapy; HAMA: Hamilton Anxiety Rating Scale; HAMD: Hamilton Depression Rating Scale; KPS: Karnofsky performance score.